The major limitation of the covidibd.org database is they don't show the correlations between parameters. In the early days of the website they used to give a full descript
ion of the fatalities (age, medication, comorbidities) which was extremely useful. I remember very clearly that the fatalities on mesalazine-only were exclusively people over 75. In other words the mesalazine is unlikely to be a cause, but something that's correlated with age and/or comorbidities (e.g. older patients are less likely to take biologics because their immune systems are weaker, and also having ibd which likely predates biologics, they are more likely to have had surgery relative to biologic use in younger ibd patients)
Regarding the overall hospitalization and death rates, these are very similar to the rates reported globally when covid first appeared and people with milder or asymptomatic cases were not tested. I can further imagine that people who get a mild case of covid may not even communicate it to their ibd doctors and data entry is purely on a voluntary basis through the ibd doctor (not like test results which are centrally logged).
I've also spoken to my GI a few months ago and he said the evidence is that ibd-ers do not fare significantly worse than the rest of the population with regard to covid.
In short, while I'm afraid of covid and the risk of triggering a flare if I'm asked to pause my medication while sick, I'm not afraid of either my medication or my UC in terms of the risk it poses to the severity of covid experienced
Post Edited (poopydoop) : 11/23/2020 2:46:31 PM (GMT-7)